BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vlaicu SI, Tatomir A, Rus V, Rus H. Role of C5b-9 and RGC-32 in Cancer. Front Immunol 2019;10:1054. [PMID: 31156630 DOI: 10.3389/fimmu.2019.01054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang F, Mu G, Liu Z, Xie Q, Zhang H, Zhou S, Wang Z, Hu K, Wang Z, Zhao X, Cui Y, Xiang Q. Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population. Genes (Basel) 2022;13:1867. [PMID: 36292752 DOI: 10.3390/genes13101867] [Reference Citation Analysis]
2 Tatomir A, Cuevas J, Badea TC, Muresanu DF, Rus V, Rus H. Role of RGC-32 in multiple sclerosis and neuroinflammation – few answers and many questions. Front Immunol 2022;13:979414. [DOI: 10.3389/fimmu.2022.979414] [Reference Citation Analysis]
3 Senent Y, Tavira B, Pio R, Ajona D. The complement system as a regulator of tumor-promoting activities mediated by myeloid-derived suppressor cells. Cancer Lett 2022;549:215900. [PMID: 36087681 DOI: 10.1016/j.canlet.2022.215900] [Reference Citation Analysis]
4 Zhang NJ, Zhang Y, Yin S, Ruan DJ, He N, Chen X, Yang XF. Nonylphenol Promoted Epithelial-Mesenchymal Transition in Colorectal Cancer Cells by Upregulating the Expression of Regulator of Cell Cycle. Chem Res Toxicol 2022. [PMID: 36074022 DOI: 10.1021/acs.chemrestox.2c00180] [Reference Citation Analysis]
5 Kolev M, Das M, Gerber M, Baver S, Deschatelets P, Markiewski MM. Inside-Out of Complement in Cancer. Front Immunol 2022;13:931273. [DOI: 10.3389/fimmu.2022.931273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liu C, Stocke K, Fitzsimonds ZR, Yakoumatos L, Miller DP, Lamont RJ. A bacterial tyrosine phosphatase modulates cell proliferation through targeting RGCC. PLoS Pathog 2021;17:e1009598. [PMID: 34015051 DOI: 10.1371/journal.ppat.1009598] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Zhu H, Yu X, Zhang S, Shu K. Targeting the Complement Pathway in Malignant Glioma Microenvironments. Front Cell Dev Biol 2021;9:657472. [PMID: 33869223 DOI: 10.3389/fcell.2021.657472] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
8 Tatomir A, Beltrand A, Nguyen V, Boodhoo D, Mekala A, Cudrici C, Badea TC, Muresanu DF, Rus V, Rus H. RGC-32 Regulates Generation of Reactive Astrocytes in Experimental Autoimmune Encephalomyelitis. Front Immunol 2020;11:608294. [PMID: 33569054 DOI: 10.3389/fimmu.2020.608294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Luo S, Wang M, Wang H, Hu D, Zipfel PF, Hu Y. How Does Complement Affect Hematological Malignancies: From Basic Mechanisms to Clinical Application. Front Immunol 2020;11:593610. [PMID: 33193442 DOI: 10.3389/fimmu.2020.593610] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
10 Goldberg BS, Ackerman ME. Antibody-mediated complement activation in pathology and protection. Immunol Cell Biol 2020;98:305-17. [PMID: 32142167 DOI: 10.1111/imcb.12324] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 12.5] [Reference Citation Analysis]